Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Complications

Effects of allogeneic bone marrow transplantation on pulmonary function in 80 children in a single paediatric centre

Summary:

We retrospectively reviewed the results of serial pulmonary function tests (PFT) after allogeneic bone marrow transplantation (BMT) performed in 80 children at a single institution over a 16-year period. We looked for associations linking PFT results to graft-versus-host disease (GVHD), conditioning regimen (total body irradiation (TBI) vs busulphan), and cytomegalovirus immune status. The median follow-up after BMT was 4 years. At 2 years after BMT, significant declines were found in forced vital capacity (FVC) and forced expiratory volume in 1 s (FEV1), as compared to baseline. Both FEV1 and the FEV1/FVC ratio showed significantly greater reductions in the group conditioned with busulphan (n=22) than in the group conditioned with TBI (n=49) and were significantly lower in the patients with (n=16) than without (n=64) chronic GVHD. Busulphan may be associated with greater long-term lung toxicity than TBI. The relevance of this finding to selection of conditioning regimens for BMT should be examined in the light of the overall pattern of side effects. Chronic GVHD was associated with airway obstruction.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Griese M, Rampf U, Hofmann D et al. Pulmonary complications after bone marrow transplantation in children: twenty-four years of experience in a single pediatric center. Pediatr Pulmonol 2000; 30: 393–401.

    Article  CAS  PubMed  Google Scholar 

  2. Cerveri I, Zoia MC, Fulgoni P et al. Late pulmonary sequelae after childhood bone marrow transplantation. Thorax 1999; 54: 131–135.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Kaplan EB, Wodell RA, Wilmott RW et al. Late effects of bone marrow transplantation on pulmonary function in children. Bone Marrow Transplant 1994; 14: 613–621.

    CAS  PubMed  Google Scholar 

  4. Fanfulla F, Locatelli F, Zoia MC et al. Pulmonary complications and respiratory function changes after bone marrow transplantation in children. Eur Respir J 1997; 10: 2301–2306.

    Article  CAS  PubMed  Google Scholar 

  5. Leneveu H, Brémont F, Rubie H et al. Respiratory function in children undergoing bone marrow transplantation. Pediatr Pulmonol 1999; 28: 31–38.

    Article  CAS  PubMed  Google Scholar 

  6. Quigley PM, Yeager AM, Loughlin GM . The effects of bone marrow transplantation on pulmonary function in children. Pediatr Pulmonol 1994; 18: 361–367.

    Article  CAS  PubMed  Google Scholar 

  7. Depledge M, Barrett A, Powles R . Lung function after bone marrow grafting. Int J Radiat Oncol Biol Phys 1983; 9: 141–151.

    Article  Google Scholar 

  8. Rodriguez-Roisin R, Granena A, Agusti AGN et al. Lung function in allogeneic bone marrow transplantation recipients. Eur Respir J 1989; 2: 359–365.

    CAS  PubMed  Google Scholar 

  9. Sutedja T, Apperley JF, Hughes JMB et al. Pulmonary function bone marrow transplantation for chronic myeloid leukaemia. Thorax 1988; 43: 163–169.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Santos GW, Tutschka PJ, Brookmeyer R et al. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. N Engl J Med 1983; 309: 1347–1353.

    Article  CAS  PubMed  Google Scholar 

  11. Cooper JAD, White DA, Matthay RA . Drug-induced pulmonary disease. Part 1: Cytotoxic drugs. Am Rev Respir Dis 1986; 133: 321–340.

    CAS  PubMed  Google Scholar 

  12. Vergnon JM, Boucheron S, Riffat J et al. Interstitial pneumopathies caused by busulfan. Histologic, developmental and bronchoalveolar lavage analysis of 3 cases. Rev Med Interne 1988; 9: 377–383.

    Article  CAS  PubMed  Google Scholar 

  13. Burns WA, McFarland W, Matthews MJ . Busulfan-induced pulmonary disease. Report of a case and review of the literature. Am Rev Respir Dis 1970; 101: 408–413.

    CAS  PubMed  Google Scholar 

  14. Barrett A . Relationship of irradiation to pulmonary complications. Exp Hematol 1984; 12: 6–7.

    Google Scholar 

  15. Weshler Z, Breuer R, Or R et al. Interstitial pneumonitis after total body irradiation: effects of total lung shielding. Br J Haematol 1990; 74: 61–64.

    Article  CAS  PubMed  Google Scholar 

  16. Deeg HJ, Sullivan KM, Buckner CD et al. Marrow transplantation for acute nonlymphoblastic leukemia in first remission: toxicity and long-term follow-up of patients conditioned with single dose or fractionated total body irradiation. Bone Marrow Transplant 1986; 1: 151–157.

    CAS  PubMed  Google Scholar 

  17. Socie G, Devergie A, Girinsky T et al. Influence of the fractionation of total body irradiation on complications and relapse rate for chronic myelogenous leukemia. The Groupe d'Etude des greffes de moelle osseuse (GEGMO). Int J Radiat Oncol Biol Phys 1991; 20: 397–404.

    Article  CAS  PubMed  Google Scholar 

  18. Keane TJ, Van Dyk J, Rider W . Idiopathic interstitial pneumonia following bone marrow transplantation: the relationship with total body irradiation. Int J Radiat Oncol Biol Phys 1981; 7: 1365–1370.

    Article  CAS  PubMed  Google Scholar 

  19. Ringden O, Remberger M, Ruutu T et al. Increased risk of graft-versus-host disease, obstructive bronchiolitis and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic bone marrow recipients with leukemia. Blood 1999; 7: 2196–2201.

    Google Scholar 

  20. De Marco R, Dassio DA, Vittone P . A retrospective study of ocular side effects in children undergoing bone marrow transplantation. Eur J Ophthalmol 1996; 6: 436–439.

    Article  CAS  PubMed  Google Scholar 

  21. Leiper AD, Stanhope R, Lau T et al. The effect of total body irradiation and bone marrow transplantation during childhood and adolescence on growth and endocrine function. Br J Haematol 1987; 67: 419–426.

    Article  CAS  PubMed  Google Scholar 

  22. Socié G, Curtis RE, Deeg HJ et al. New malignant diseases after allogeneic marrow transplantation for childhood acute leukaemia. J Clin Oncol 2000; 18: 348–357.

    Article  PubMed  Google Scholar 

  23. Prince DS, Wingard JR, Saral R et al. Longitudinal changes in pulmonary function following bone marrow transplantation. Chest 1989; 96: 301–306.

    Article  CAS  PubMed  Google Scholar 

  24. Clark JG, Crawford SW, Madtes DK et al. Obstructive lung disease after allogeneic marrow transplantation. Ann Intern Med 1989; 111: 368–376.

    Article  CAS  PubMed  Google Scholar 

  25. Clark JG, Schwartz DA, Flournoy N et al. Risk factors for airflow obstruction in recipients of bone marrow transplants. Ann Intern Med 1987; 107: 648–656.

    Article  CAS  PubMed  Google Scholar 

  26. Link H, Reinhard U, Blaurock M et al. Lung function changes after allogenic bone marrow transplantation. Thorax 1986; 41: 508–512.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Wyatt SE, Nunn P, Hows JM et al. Airways obstruction associated with graft versus host disease after bone marrow transplantation. Thorax 1984; 39: 887–894.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Curtis DJ, Smale A, Thien F et al. Chronic airflow obstruction in long-term survivors of allogeneic bone marrow transplantation. Bone Marrow Transplant 1995; 16: 169–173.

    CAS  PubMed  Google Scholar 

  29. Epler GR . Bronchiolitis obliterans and airways obstruction associated with graft-versus-host disease. Clin Chest Med 1988; 9: 551–556.

    CAS  PubMed  Google Scholar 

  30. McDonald GB, Sullivan KM, Schuffler MD et al. Esophageal abnormalities in chronic graft-versus-host disease in humans. Gastroenterology 1981; 80: 914–921.

    CAS  PubMed  Google Scholar 

  31. Schubert MM, Sullivan KM, Morton TH . Oral manifestations of chronic graft-v-host disease. Arch Intern Med 1984; 144: 1591–1595.

    Article  CAS  PubMed  Google Scholar 

  32. Izutsu KT, Sullivan KM, Schubert MM . Disordered salivary immunoglobulin secretion and sodium transport in human chronic graft-versus-host disease. Transplantation 1983; 35 (Suppl 5): 441–446.

    Article  CAS  PubMed  Google Scholar 

  33. Bleyzac N, Souillet G, Magron P et al. Improved clinical outcome of paediatric bone marrow recipients using a test dose and Baysian pharmacokinetic individualization of busulfan dosage regimens. Bone Marrow Transplant 2001; 28: 743–751.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to B Bruno.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bruno, B., Souillet, G., Bertrand, Y. et al. Effects of allogeneic bone marrow transplantation on pulmonary function in 80 children in a single paediatric centre. Bone Marrow Transplant 34, 143–147 (2004). https://doi.org/10.1038/sj.bmt.1704549

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704549

Keywords

This article is cited by

Search

Quick links